임상 단백질체학 시장 : 기술, 응용 및 전망(-2030년)

Kalorama Information’s The Clinical Proteomics Market: Technologies, Applications, and Forecasts to 2030 examines the market for proteomics technologies as applied to clinical and pharmaceutical settings, with particular attention to next-generation platforms - the instruments, consumables, and reagent kits that enable systematic, multiplexed protein measurement for clinical research, trial biomarker work, and, increasingly, patient diagnostics.

The report addresses a central tension in this field: most revenue currently associated with “clinical” proteomics comes from research and pharmaceutical development rather than diagnostic testing. Systematic and multiplex protein analysis platforms are widely used in biomarker discovery, trial stratification, and population-scale studies, while a smaller number of applications - concentrated in neurology, certain cancers, and oncology triage - have reached actual clinical use. The report tracks the technologies, companies, and commercial developments defining how that landscape is evolving.

Coverage includes the major measurement approaches shaping the field - mass spectrometry, high-plex affinity and binder-based assays, ultrasensitive digital immunoassays, spatial and single-cell proteomics, and emerging single-molecule protein sequencing - along with the enrichment, separation, and sample-preparation technologies that support them. The report discusses key structural trends affecting the market, including the ongoing consolidation of proteomics companies into larger instrument and diagnostics platforms, the migration of affinity-based assays onto sequencing and PCR infrastructure, the role of the LDT/CLIA regulatory pathway in clinical commercialization, and the shifting balance between instrument sales and services-based revenue.

The Clinical Proteomics Market: Technologies, Applications, and Forecasts to 2030 provides estimated market size data segmented by technology and region for 2025, profiles of companies active across the proteomics value chain, and a review of recent product introductions, regulatory approvals, and deal activity shaping the competitive environment.

Scope and methodology

The Clinical Proteomics Market: Technologies, Applications, and Forecasts to 2030 focuses on instrument, consumable, and reagent/kit revenue associated with systematic or multiplexed protein analysis technologies used in clinical research, clinical trial biomarker measurement, and clinical diagnostics. Contract research and clinical laboratory testing services are discussed but are not included in the core revenue estimates, in part to avoid double-counting revenue already reflected in product sales. Research for this report draws on primary interviews, company financial disclosures, product literature, conference proceedings, and journal and trade publication review.

Research Designed for C-Suite Executives, Key Companies, and More

The Clinical Proteomics Market: Technologies, Applications, and Forecasts to 2030 is intended for executives, strategy and business development teams, investors, laboratory and pharmaceutical biomarker leaders, and marketing professionals working in or evaluating the clinical proteomics space.

CHAPTER 1: EXECUTIVE SUMMARY

ABOUT KALORAMA INFORMATION

INTRODUCTION

Overview

Trends Affecting the Market

SIZE OF MARKET

• Table 1-1: Proteomics Clinical Applications Market Revenues, 2025-2030 (US$ millions)
• Figure 1-1: Proteomics Clinical Applications Market Revenues, 2025-2030 (US$ millions)
• Figure 1-2: Proteomics Clinical Applications Annual Market Growth, 2025-2030 (%)

SCOPE AND METHODOLOGY

CHAPTER 2: TECHNOLOGIES AND PRODUCTS

INTRODUCTION

TECHNOLOGIES USED IN CLINICAL APPLICATIONS OF PROTEOMICS

Mass Spectrometry

High-Plex Capable Affinity Techniques

Spatial Proteomics

Mass Cytometry

Automated and Capillary Western

Single-Molecule Protein Sequencing

PRODUCTS OFFERED IN CLINICAL PROTEOMICS AREAS

Analysis / Detection Platforms

• Table 2-1: Selected Analysis and Detection Technologies in Clinical Proteomics

Mass Spectrometry Based Technologies

• Table 2-2: Selected Mass Spectrometry Technologies in Clinical Proteomics

Affinity and Binder Based Techniques

• Table 2-3: Selected Affinity and Binder Based Techniques in Clinical Proteomics

Enrichment, Separation, Sample Preparation

• Table 2-4: Selected Enrichment, Separation, Sample Preparation Products and Technologies

Spatial Proteomics and Imaging Techniques

• Table 2-5: Selected Spatial Proteomics and Imaging Techniques in Clinical Proteomics

Software and Informatics

• Table 2-6: Selected Software and Informatics in Clinical Proteomics

Clinical Diagnostic and Biomarker Tests

• Table 2-7: Selected Diagnostic Tests in or Related to Clinical Proteomics

Services and Contract Research

• Table 2-8: Selected Services in Clinical Proteomics

CHAPTER 3: TRENDS

INTRODUCTION

Consolidation as Larger Companies Focus Strategy

Detection Methods Competing, Some Converging

Sequencing Infrastructure Applied as Proteomics Readout

Dynamic Range and Sensitivity Are Battleground

Cost and Throughput Unlocking Population-Scale Proteomics

Neurology Emerges as Beachhead Clinical Application

Oncology Broadening From Detection

Commercialization Often Using LDT/CLIA Model

Spatial and Single-Cell Proteomics on Frontier

Capital Markets Soft, Services and Pharma Steadier Ground

Evolving Technologies and Adjacent Products

RECENT PRODUCT INTRODUCTIONS AND REGULATORY APPROVALS

• Table 3-1: Recent Product / Service Announcements, 2021-2026
• Table 3-2: Regulatory Approvals and Related Announcements, 2021-2026

DEALS, COLLABORATIONS, ACQUISITIONS

• Table 3-3: Deals, Collaborations, Acquisitions in Clinical Applications of Proteomics

CHAPTER 4: MARKET ESTIMATE AND FORECAST

INTRODUCTION

MARKET SIZE AND FORECAST BY SEGMENT

• Table 4-1: Proteomics Clinical Applications Market Revenues, 2025-2030 (US$ millions)
• Figure 4-1: Proteomics Clinical Applications Market Revenue Build, 2025-2030 (US$ millions)

MARKET SIZE BY REGION

• Table 4-2: Proteomics Clinical Applications Market, by Region, 2025 (US$ millions)
• Figure 4-2: Proteomics Clinical Applications Market, by Region, 2025 (US$ millions)
• Figure 4-3: Proteomics Clinical Applications Market Share, by Region, 2025 (%)

MARKET SIZE BY TECHNOLOGY

• Table 4-3: Proteomics Clinical Applications Market, by Technology, 2025 (US$ millions) [Affinity-based, MS-based, Ultrasensitive digital immunoassay, Other]
• Figure 4-4: Proteomics Clinical Applications Market, by Technology, 2025 (US$ millions) [Affinity-based, MS-based, Ultrasensitive digital immunoassay, Other]
• Figure 4-5: Proteomics Clinical Applications Market Share, by Technology, 2025 (%) [Affinity-based, MS-based, Ultrasensitive digital immunoassay, Other]

CHAPTER 5: COMPANY PROFILES

INTRODUCTION

ALAMAR BIOSCIENCES

BIO-TECHNE

BRUKER

CELLENION

EVOSEP

ILLUMINA

NANOMICS

NANOMOSAIC

NAUTILUS BIOTECHNOLOGY

NOMIC BIO

QUANTERIX

QUANTUM-SI

SCIEX

SEER

STANDARD BIOTOOLS

THERMO FISHER SCIENTIFIC